Company intelligence
Biotech CEO Sisterhood
Inspiring a community of leaders to ignite change and drive biopharma impact.
About Biotech CEO Sisterhood
The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness.
Verified activity
Signals from Biotech CEO Sisterhood
9 published signals
Presence & Recognition
Biotech CEO Sisterhood featured Rachel King in a new BiotechTV conversation with sisterhood member Erika Smith about thriving CEOs
Reported by Biotech CEO Sisterhood
Presence & Recognition
Biotech CEO Sisterhood, Biotech CFO Sisterhood, Biotech COBO Sisterhood, and Biotech CDO/CTO Sisterhood cohorts attended an AI training session delivered by Sam Keller and his team at Gen AI Academy.
Reported by Biotech CEO Sisterhood
Legal & Regulatory
Biotech CEO Sisterhood member Julie Kim and the Takeda team secured the FDA approval for MIMRYLO™, the first hepcidin mimetic approved for erythrocytosis in adults with PV.
Reported by Biotech CEO Sisterhood
Presence & Recognition
Biotech CEO Sisterhood member Najat Khan, PhD and the Recursion team received an award
Reported by Biotech CEO Sisterhood
Presence & Recognition
Biotech CEO Sisterhood member Katherine Stueland was named a Fierce50 winner.
Reported by Biotech CEO Sisterhood
Capital & Finance
Biotech CEO Sisterhood member Kathy Dong is leading Electra Therapeutics to raise capital to advance its late-stage immunology candidate, ipsoprubart (ELA026), a pan-SIRP monoclonal antibody.
Reported by Biotech CEO Sisterhood
Capital & Finance
Biotech CEO Sisterhood member Kathy Dong is leading Electra Therapeutics to an IPO during a strong year for biotech markets with more than 20 biotech companies having gone public in 2026 alone.
Reported by Biotech CEO Sisterhood
Capital & Finance
Biotech CEO Sisterhood member Kathy Dong is leading Electra Therapeutics to advance its second SIRP-focused antibody, ELA822, in Phase 1 in Europe with a planned Phase 1/2 trial in T cell-mediated immune disorders.
Reported by Biotech CEO Sisterhood
Capital & Finance
Biotech CEO Sisterhood member Kathy Dong is leading Electra Therapeutics into the public markets with Sanofi among existing equity backers.
Reported by Biotech CEO Sisterhood